Clinical Trials Logo

Clinical Trial Summary

The primary goal of the study is to evaluate the safety of the EndoLift Liver Retractor as an internal laparoscopic liver retraction device. The secondary goals of the study are to evaluate the efficacy of the EndoLift Liver Retractor as an internal laparoscopic liver retraction device and to identify 'best practices' for device utilization.

This study evaluates the use of a specific type of liver retractor (EndoLift). Liver retractors are often necessary during MIS procedures, but this retractor is the only device which is deployed internally (NOT requiring additional skin punctures/incisions for placement of the liver retractor device). All patients undergoing minimally invasive surgery (MIS) at Duke Regional Hospital will be approached.

The new device is expected to have a minimal risk safety profile. The investigators believe that these risks are no more than would be encountered by using any other commercially available retraction device available on the market today. Data will be collected and analyzed by the identified investigators. Continuous variables will be analyzed via T-test and Chi-square analysis will be applied to discontinuous variables. Statistical analysis software such as SPSS® will be utilized when necessary.


Clinical Trial Description

Since the introduction of minimally invasive surgery (MIS) techniques in the 1980's laparoscopic surgery has become the preferred approach for a number of intra-abdominal procedures such as cholecystectomy, gastric bypass, etc.[1] One of the key components of laparoscopic surgery, of any surgery for that matter, is the ability to achieve and maintain adequate visualization of the surgical target throughout the procedure. During certain MIS procedures the patient's internal organs, such as the liver, can block or obscure the surgical view. A number of surgical instruments (retractors) have been developed to help retract abdominal organs "out of the way" during MIS procedures, but all of these devices require an additional abdominal wall puncture/incision to adequately position the device.

Virtual Ports, Ltd. has developed a new laparoscopic liver retractor device, the EndoLift Liver Retractor. This new device does not require additional skin incisions and is placed internally (inside the abdomen) during laparoscopic surgery. The device has 2 ends that "grab" tissue. The body of the device is a smooth, cylindrical steel bar that has minimal risk of traumatizing tissues/organs. The ends of the device are positioned on to peritoneal surfaces (e.g., anterior abdominal wall and/or the right crus of the diaphragm) and the body of the device (smooth cylindrical bar) "pushes" the liver away from the surgical field. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT02008409
Study type Interventional
Source Duke University
Contact
Status Withdrawn
Phase N/A
Start date November 2011
Completion date February 2014

See also
  Status Clinical Trial Phase
Withdrawn NCT04771247 - Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy N/A
Not yet recruiting NCT05485363 - Non-invasive Assessment of Intracranial Pressure Using Ocular Sonography in Patients Undergoing Laparoscopic Sleeve Gastrectomy N/A
Terminated NCT02762487 - RELIEF Europe Study N/A
Completed NCT06052111 - Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy N/A
Completed NCT06284356 - Pan Immune Inflammation Value for Perioperative Complications of Laparoscopic Sleeve Gastrectomy
Recruiting NCT06305221 - Effect of Opioid-free Analgesia and Anesthesia on the Quality of Postoperative Recovery and Nausea Vomit in Patients Receiving Laparoscopic Sleeve Gastrectomy N/A
Active, not recruiting NCT05873270 - Randomized, Controlled, Single-blind Exploratory Study of the Efficacy and Safety of Wrist and Ankle Acupuncture Intervention on Nausea, Vomiting and Pain After Sleeve Gastric Surgery in Women
Completed NCT03051919 - Reinforcement Method in Laparoscopic Sleeve Gastrectomy N/A
Withdrawn NCT04452786 - Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty N/A
Recruiting NCT05224791 - A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy
Completed NCT04264364 - ESG vs LSG: Short-term Nutritional Outcomes
Completed NCT03629808 - Laparoscopic Sleeve Gastrectomy: a Cohort Study
Not yet recruiting NCT04323696 - Comparison of Staple Line Suturing in Laparoscopic Sleeve Gastrectomy N/A
Not yet recruiting NCT04442568 - Impact of ERAS in LSG N/A
Recruiting NCT04151459 - Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients N/A
Completed NCT04439851 - Impact of Sleeve Gastrectomy on Monocyte-to-High-Density Lipoprotein Cholesterol Ratio
Completed NCT03856788 - Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery Phase 4
Completed NCT03435003 - Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy Phase 4
Recruiting NCT05516953 - Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery Phase 2/Phase 3
Completed NCT03983122 - Outcomes of Laparoscopic Sleeve Gastrectomy N/A